1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

Perrigo Results Reach A Valley Before Peak Expected From Opill Launch, Private Label Gains

 
• By Malcolm Spicer

Perrigo investing in preparing marketplace for Opill and educating consumers about it and reports trend of sales volumes increasing for private label/store brand consumer health portfolio.

• Source: Shutterstock

Perrigo Company PLC’s marketing of national brands on top of its leading private label and store brand portfolio is encountering a downside before reaching the expected upside of results showing the best of both worlds.

On one hand, while the firm’s launch of sales of the first US OTC daily oral contraceptive branded Opill, planned for early 2024, will be dilutive to its earnings in the first year, Perrigo also is reporting its private label and store brand OTC

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health